/Companies

Ambros Therapeutics

acquired by Werewolf Therapeutics

San Diego, US · 10 known investors

Find your way into Ambros Therapeutics

Sign up to see every warm intro you have to Ambros Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Ambros Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Acquired by Werewolf Therapeutics August 2026 · $500M (Ambros valued at $500 million pre-money; $150 million concurrent private placement) · source ↗

Ambros Therapeutics is a therapeutics company.

Founders & leadership

J(Joseph (Jay) Hagan
Joseph (Jay) HaganPresident and Chief Executive Officer

Investors · 10

Also in the syndicate · 5

Abiogen PharmaAdage Capital Partners LPArkin BioEnavate SciencesleadTranshuman Capital

Funding

SEC filings, press & company announcements

$125M disclosed across 1 round · 2025

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Ambros Therapeutics do?
Ambros Therapeutics is a therapeutics company.
Who are Ambros Therapeutics's investors?
Ambros Therapeutics's investors include LifeSci Venture Partners, RA Capital, BAM Elevate, Janus Henderson Investors, Patient Square Capital.
How much funding has Ambros Therapeutics raised?
Ambros Therapeutics has disclosed $125M raised across 1 round.
Who acquired Ambros Therapeutics?
Ambros Therapeutics was acquired by Werewolf Therapeutics.
Where is Ambros Therapeutics headquartered?
Ambros Therapeutics is headquartered in San Diego, US.